The Jambor-McCarthy legacy: A $21.4 million Gift Twenty Years in the Making
…just a brief interruption of Dr. Shah’s posts, to share some exciting breaking news: This morning, we announced the largest charitable bequest to a single …
General
A closer look at acute myeloid leukemia (AML)
Eventually, I wanted to enhance the bridging of my clinical and research work, and the BC Cancer Agency was—and continues to be—a …
About me—From Queen’s to Vancouver
Hello, my name is Aly Karsan and I am the head of the Centre for Clinical Diagnostic Genomics and the Medical Director of the …
Cancer Speak: November 4, 2011
I’m really excited about what’s to come with Dr. Aly Karsan’s posts, but I had to take this chance to talk about some timely …
Introducing Dr. Aly Karsan
Around the office at the BC Cancer Foundation we are still thrilled with the success of last week’s Inspiration Gala event. To those …
Phase I Clinical Trials and Drug Development
Dr. Gelmon continues her blog for the BC Cancer Foundation, talking about Phase I Clinical Trials and Drug Development.
Understanding Tumours
When I began treating breast cancer, we treated patients according to whether they were pre-menopausal or not, and whether there was any sign of …
Oncology: We’ve come along way
My name is Karen Gelmon and I am a medical oncologist. As a medical oncologist at the BC Cancer Agency, I see patients with …
Introducing Dr. Karen Gelmon
Dr. Gelmon is out guest blogger for October 2011! Thank you to Dr. Spinelli for acquainting us with the BC Generations Project and sharing how …
Dr. Huntsman looking to the future of OVCARE – an internationally recognized entity
Our first five-year plan for the Ovarian Cancer Research program (OVCARE) is nearly complete. During these first five years, OVCARE has grown from …